Pacira BioSciences (PCRX) Stock
Pacira BioSciences (PCRX) closed at $36.48 on Nov 16, 2026; its Tenet Score is 56 of 100 against 340 Healthcare peers.
6 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $36.48
- Nov 16, 2026
- Market cap
- $1.5B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 39.5×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 18.80 – 36.66
- low → high · as of close, Nov 17, 2026
- Tenet Score
- 56/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Pacira BioSciences Inc scores 56/100. Mixed. Strongest on quality, trading at 39× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ✓ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ~ Quality Compounder
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamc…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 17, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| ANI Pharmaceuticals IncANIP | 69 | $1.6B |
| Vir Biotechnology IncVIR | 54 | $1.6B |
| Sarepta Therapeutics IncSRPT | 48 | $1.6B |
| Nurix Therapeutics IncNRIX | 84 | $1.6B |
| UroGen Pharma LtdURGN | 44 | $1.5B |
| uniQure N.V.QURE | 37 | $1.5B |
| Immunocore Holdings plcIMCR | 53 | $1.4B |
| Intellia Therapeutics IncNTLA | 41 | $1.4B |
| AlvotechALVO | 41 | $1.4B |
| AnaptysBio IncANAB | 53 | $1.4B |
Common questions
What sector and industry is Pacira BioSciences in?
Pacira BioSciences is in the Healthcare sector and the Drugs industry.
What is Pacira BioSciences' Tenet Score?
Pacira BioSciences' Tenet Score is 56 out of 100, ranked against 340 Healthcare peers as of Nov 17, 2026.




